| Nodular Lymphocyte Predominant B-Cell Lymphoma studied in …STUDIED_INderived16 of 16show fewer |
|---|
| → studied in | NCT05886036Phase 2 · recruiting Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial · condition mapped ONTOLOGY_EXACT · 16 trials mapped (3 active) | — | — | Nodular Lymphocyte Predominant B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04799275Phase 2/Phase 3 · active not recruiting Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 16 trials mapped (3 active) | — | — | Nodular Lymphocyte Predominant B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00107198Phase 2 · completed Treating Young Patients With Newly Diagnosed, Low Stage, Lymphocyte Predominant Hodgkin Disease · condition mapped ONTOLOGY_EXACT · 16 trials mapped (3 active) | — | — | Childhood Nodular Lymphocyte Predominant B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06098430recruiting Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) · condition mapped CURATED_BROADER · 16 trials mapped (3 active) | — | — | Nodular Lymphocyte Predominant B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01588015Phase 1 · completed Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant · condition mapped ALIAS · 16 trials mapped (3 active) | — | — | Adult Nodular Lymphocyte Predominant B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04858568completed Immune Responses to COVID-19 Vaccination in Lymphoma Patients · condition mapped CURATED_BROADER · 16 trials mapped (3 active) | — | — | Nodular Lymphocyte Predominant B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01026220Phase 3 · completed Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma · condition mapped ALIAS · 16 trials mapped (3 active) | — | — | Childhood Nodular Lymphocyte Predominant B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01535924Phase 1/Phase 2 · completed Gemcitabine and Bendamustine in Patients With Relapsed or Refractory Hodgkin's Lymphoma · condition mapped ALIAS · 16 trials mapped (3 active) | — | — | Adult Nodular Lymphocyte Predominant B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02626884Phase 2 · completed Ibrutinib in Relapsed Nodular Lymphocyte-predominant Hodgkin Lymphoma (NLPHL) · condition mapped ALIAS · 16 trials mapped (3 active) | — | — | Nodular Lymphocyte Predominant B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00381940Phase 2 · completed Bortezomib, Ifosfamide, and Vinorelbine Tartrate in Treating Young Patients With Hodgkin's Lymphoma That is Recurrent or Did Not Respond to Previous Therapy · condition mapped ALIAS · 16 trials mapped (3 active) | — | — | Adult Nodular Lymphocyte Predominant B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01460940Phase 2 · completed A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma · condition mapped ALIAS · 16 trials mapped (3 active) | — | — | Adult Nodular Lymphocyte Predominant B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003820Phase 2 · completed Rituximab in Treating Patients With Hodgkin's Lymphoma · condition mapped CURATED_BROADER · 16 trials mapped (3 active) | — | — | Nodular Lymphocyte Predominant B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00025259Phase 3 · completed Chemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children With Newly Diagnosed Hodgkin's Disease · condition mapped ALIAS · 16 trials mapped (3 active) | — | — | Childhood Nodular Lymphocyte Predominant B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01187303Phase 2 · completed Ofatumumab in Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) · condition mapped CURATED_BROADER · 16 trials mapped (3 active) | — | — | Nodular Lymphocyte Predominant B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00288067Phase 1/Phase 2 · terminated Fenretinide and Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma · condition mapped ALIAS · 16 trials mapped (3 active) | — | — | Adult Nodular Lymphocyte Predominant B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00132028Phase 2 · completed Vorinostat in Treating Patients With Relapsed or Refractory Advanced Hodgkin's Lymphoma · condition mapped ALIAS · 16 trials mapped (3 active) | — | — | Adult Nodular Lymphocyte Predominant B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |